Accelrys, Linux | GenomeWeb

Accelrys, Linux


Accelrys Q2 Revenues Down 12 Percent, Bangalore Unit Operational

Pharmacopeia last week reported that second-quarter revenues for its Accelrys software subsidiary dropped 12 percent compared to the year-ago period, from $21.4 million to $19 million.

Total revenue for Pharmacopeia’s 2003 second quarter was $26.1 million, including the company’s drug discovery services, a decrease of $3.2 million from the $29.3 million reported in the second quarter of 2002.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.